ethylcholine aziridinium has been researched along with latrepirdine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachurin, SO; Lermontova, NN; Lukoyanov, NV; Lukoyanova, EA; Serkova, TP | 1 |
| Bachurin, SO; Lermontova, NN; Nikolaeva, NS; Serkova, TP; Shevtsova, EF; Van'kin, GI; Vasilieva, NA | 1 |
2 other study(ies) available for ethylcholine aziridinium and latrepirdine
| Article | Year |
|---|---|
Dimebon improves learning in animals with experimental Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Choline; Cholinesterase Inhibitors; Disease Models, Animal; Histamine H1 Antagonists; Indoles; Injections, Intraventricular; Male; Neuromuscular Blocking Agents; Rats; Rats, Wistar; Tacrine | 2000 |
Wave-Like Dose-Dependence of the Stimulating Effects of Dimebon on Cognition in a Wide Dose Range.
Topics: Alzheimer Disease; Animals; Aziridines; Biological Clocks; Central Nervous System Stimulants; Choline; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Maze Learning; Mice; Mice, Inbred C57BL; Pattern Recognition, Physiological; Rats; Rats, Wistar | 2019 |